More than 130 companies and 15,000 employees work in health research and development. Comprising large companies as well as innovative SMEs and start-ups, the health cluster is focused on areas that are likely to experience significant growth in the years to come. Oriented to respond to the challenges of biopharmacy and biomedical engineering, it specializes notably in understanding the brain and the genome, as well as in the treatment of cancer and diabetes.
The underlying trend is towards the increased digitization of the sector, with the use of ICT in various forms, particularly in medical imaging (MRI, scanners). Another up-and-coming field is nutrition, which is becoming more closely tied to the health sector with the development of “nutricaments”.